This grant, offered by the HEAL Initiative, invites cooperative agreement applications for multisite embedded pragmatic or implementation trials. The purpose is to inform the uptake of various approaches—pharmacologic, nonpharmacologic, or multicomponent—for managing acute and/or chronic sickle cell disease (SCD) pain within healthcare systems. While trials may incorporate opioid medication, it should not be the sole intervention. This initiative encourages studies that implement, improve adherence to, or evaluate the effectiveness of pain management guidelines for SCD patients. Furthermore, trials may address critical social and structural barriers, such as stigma and racial bias, that impact effective SCD pain management care.
Opportunity ID: 342287
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AT-23-001 |
| Funding Opportunity Title: | HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 13, 2022 |
| Last Updated Date: | Jul 13, 2022 |
| Original Closing Date for Applications: | Nov 21, 2022 |
| Current Closing Date for Applications: | Nov 21, 2022 |
| Archive Date: | Dec 27, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Public housing authorities/Indian housing authorities State governments Special district governments County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to solicit cooperative agreement applications to conduct multisite embedded pragmatic or implementation trials to inform the uptake of pharmacologic, nonpharmacologic, and/or multicomponent approaches for acute and/or chronic sickle cell disease (SCD) pain management in health care systems that serve the SCD population. Trials may include or allow continuation of opioid medication as needed; however opioid medication use alone should not be the only intervention studied. Trials may propose methods to implement, improve adherence, or evaluate the effectiveness of guidelines for pain management in patients with SCD in various health care settings. Trials supported under this initiative could also address social and structural barriers such as stigma and racial bias to SCD pain management care. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-23-001.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 342287 Full Announcement-RFA-AT-23-001 -> RFA-AT-23-001-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00275915 | Oct 21, 2022 | Nov 21, 2022 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278456 | Nov 15, 2022 | Nov 21, 2022 | View |
Package 1
Mandatory forms
342287 RR_SF424_5_0-5.0.pdf
342287 PHS398_CoverPageSupplement_5_0-5.0.pdf
342287 RR_OtherProjectInfo_1_4-1.4.pdf
342287 PerformanceSite_4_0-4.0.pdf
342287 RR_KeyPersonExpanded_4_0-4.0.pdf
342287 RR_Budget_3_0-3.0.pdf
342287 PHS398_ResearchPlan_4_0-4.0.pdf
342287 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342287 RR_SubawardBudget30_3_0-3.0.pdf
342287 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
342287 RR_SF424_5_0-5.0.pdf
342287 PHS398_CoverPageSupplement_5_0-5.0.pdf
342287 RR_OtherProjectInfo_1_4-1.4.pdf
342287 PerformanceSite_4_0-4.0.pdf
342287 RR_KeyPersonExpanded_4_0-4.0.pdf
342287 RR_Budget_3_0-3.0.pdf
342287 PHS398_ResearchPlan_5_0-5.0.pdf
342287 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342287 RR_SubawardBudget30_3_0-3.0.pdf
342287 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
